Page last updated: 2024-12-07
3,4,6-tri-o-acetylglucal
Description
3,4,6-tri-o-acetylglucal is a synthetic derivative of glucal, a naturally occurring sugar. It is synthesized by acetylation of glucal, typically using acetic anhydride and a base catalyst. 3,4,6-tri-o-acetylglucal is a versatile building block in organic synthesis, particularly for the preparation of glycosides and other carbohydrate derivatives. It has been studied extensively for its potential applications in medicinal chemistry and carbohydrate chemistry. For example, it has been used in the synthesis of antiviral agents, anti-inflammatory drugs, and carbohydrate mimetics. The compound's unique reactivity and structural features make it a valuable tool for exploring the synthesis of novel carbohydrate-based molecules.'
3,4,6-tri-O-acetylglucal: RN given refers to (D)-isomer with unspecified acetate locants [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
PubMed CID | 102891 |
SCHEMBL ID | 12083311 |
MeSH ID | M0127571 |
Synonyms (33)
Synonym |
d-arabino-hex-1-enitol, 1,5-anhydro-2-deoxy-, triacetate |
LS-14102 |
nsc66181 |
nsc-66181 |
nsc287428 |
nsc-287428 |
(3,4-diacetyloxy-3,4-dihydro-2h-pyran-2-yl)methyl acetate |
d-glucal triacetate |
einecs 223-859-5 |
3,4,6-tri-o-acetylglucal |
2,6-anhydro-5-deoxy-d-arabino-hex-5-enitol triacetate |
1,5-anhydro-2-deoxy-d-arabino-hex-1-enitol triacetate |
einecs 220-709-0 |
FT-0624544 |
FT-0634522 |
AM84889 |
tri-o-acetylglucal |
SY009244 |
mfcd00063253 |
SCHEMBL12083311 |
d-arabino-hex-1-enopyranose, 1,2-dideoxy-, triacetate |
LLPWGHLVUPBSLP-UHFFFAOYSA-N |
tri-o-acetyl-l-glucal |
1,3,4-tri-o-acetyl-2,6-anhydro-5-deoxyhex-5-enitol |
AKOS030212726 |
mfcd00064092 |
SY017625 |
FT-0773735 |
d-arabino-hex-1-enitol, 1,5-anhydro-2-deoxy-, 3,4,6-triacetate |
1,5-anhydro-2-deoxy-d-arabino-hex-1-enitol3,4,6-tri-o-acetyl |
DTXSID90863045 |
2-(acetoxymethyl)-3,4-dihydro-2h-pyran-3,4-diyl (2r,3s,4s)-diacetate |
SY356451 |
Research
Studies (11)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 1 (9.09) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (45.45) | 29.6817 |
2010's | 3 (27.27) | 24.3611 |
2020's | 2 (18.18) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 11.85
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
Metric | This Compound (vs All) |
---|
Research Demand Index | 11.85 (24.57) | Research Supply Index | 2.48 (2.92) | Research Growth Index | 4.34 (4.65) | Search Engine Demand Index | 0.00 (26.88) | Search Engine Supply Index | 0.00 (0.95) |
| |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 11 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |